arBtrage CAPITALIZING MARKETS checking… Sign in

Gossamer Bio, Inc.

GOSS Health Care Biotechnology: Pharmaceutical Preparations
$0.17
▼ -1.6% Today
as of Jun 7, 07:16 ET
Last 30 days -49.28% Apr 28 → Jun 05
$0.16 $0.22 $0.27 $0.33 $0.39 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.18
High
$0.18
Low
$0.17
Volume
$10M
Avg Vol
$8M
Mkt Cap
$50M
P/E (TTM)
Beta
52w High
$3.87
52w Low
$0.16
Div Yield
Shares Out
$235M

Overview

52-week range
$0.16
$3.87
0% of range
Avg surprise (last 2)
-3.3%
Avg reaction (last 2)
+3.5%
100% positive
Latest IV / EM
2475%
EM ±342.9% · $1 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.45$-0.28$-0.11$0.05$0.22 Actual $-0.45Actual $-0.21Actual $-0.19Actual $0.22Actual $-0.14Actual $-0.16Est $-0.18Actual $-0.17Actual $-0.21Actual $-0.20Est $-0.17 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-48M$-11M$26M$63M$101M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.20 $-0.17 -17.6% -25.0% +3.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.21 financials
Mon Jun 30, 2025Jun 2025 $-0.17 financials
Thu May 15, 2025Mar/2025 $-0.16 $-0.18 +11.1% +4.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.14 financials
Sun Jun 30, 2024Jun 2024 $0.22 financials
Sun Mar 31, 2024Mar 2024 $-0.19 financials
Sat Sep 30, 2023Sep 2023 $-0.21 financials
Fri Jun 30, 2023Jun 2023 $-0.45 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$17M$13M$11M$10M$9M$96M
Cost of revenue
Gross profit
Operating income$-45M$-49M$-39M$-37M$-34M$52M
Net income$-47M$-48M$-38M$-37M$-31M$49M
EPS (diluted)$-0.20$-0.21$-0.17$-0.16$-0.14$0.22

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$41M$38M$9M$26M$29M$46M$28M$87M
Inventory
Total current assets$125M$168M$204M$236M$275M$310M$344M$371M
Total assets$129M$172M$209M$241M$281M$315M$351M$373M
Long-term debt$0$0
Total liabilities$290M$295M$291M$287M$287M$286M$297M$292M
Total equity$-161M$-123M$-82M$-46M$-6M$29M$54M$82M

Implied volatility — last 90 days

2470%2472%2475%2477%2480% Jun 07 — IV 2475% · EM ±342.9%

Sector peers